CytoMed Therapeutics Limited — Liquidità (NASDAQ:GDTC)

Financials

Flusso di cassa derivante dalle attività operative -1.04 M-2.6 M-1.98 M-2.88 M — Flussi di cassa derivanti dalle attività di investimento -353.11 K-2.14 M824.58 K722.67 K — Liquidità derivante dalle attività di finanziamento 722.71 K8.28 M-47.5 K162.26 K — Liquidità libera -1.04 M-2.6 M-1.98 M-2.88 M —

Notizie

Il titolo di CytoMed balza dopo l’annuncio di partnership per trial clinico in Malesia

CytoMed stock jumps after announcing clinical trial partnership in Malaysia

CytoMed Therapeutics enters clinical trial agreement with Malaysian hospital

CytoMed Therapeutics secures $500,000 investment for subsidiary

CytoMed Therapeutics Limited (GDTC) Q2 2025 Earnings Call Prepared Remarks Transcript

CytoMed riporta risultati preclinici promettenti per il trattamento della leucemia

CytoMed reports promising preclinical results for leukemia treatment

CytoMed Therapeutics shareholders approve all proposals at annual meeting

CytoMed Therapeutics schedules annual shareholder meeting